← Back to home

FDA Says Jemperli May Let Some Rectal Cancer Patients Avoid Surgery, Chemo and Radiation

Fact checked by NewsPlainVerified by NewsPlain: confirmed by at least two named sources

Brief

The Food and Drug Administration on Monday, Oct. 19, granted accelerated approval to GSK's immunotherapy Jemperli for adults with stage II or stage III locally…

Keep reading with NewsPlain Premium

Get the full brief, the full story, what's confirmed, what's still unclear, why it matters, and every source.

3 sources behind this story.

About this story

We haven’t published a correction to this story.

How NewsPlain works
← Back to home